4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-0145 |
| Compound Name: | 4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 454.5 |
| Molecular Formula: | C22 H22 N4 O5 S |
| Smiles: | Cc1nc(CN2C(COc3ccc(cc23)S(NC2CCCc3ccccc23)(=O)=O)=O)no1 |
| Stereo: | RACEMIC MIXTURE |
| logP: | 3.0472 |
| logD: | 3.0468 |
| logSw: | -3.5561 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 98.051 |
| InChI Key: | YJILBERWDOAWPE-SFHVURJKSA-N |